Dextromethorphan Is a Novel Pharmacological Inhibitor of F 1 F O ‐ ATPase That Targets the Membrane‐Embedded Domain Impairing ATP Synthesis and Hydrolysis
BioFactors · 2026-01 · 52 (1)
DOI: 10.1002/biof.70076 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, online erschienen am 05.01.2026. Verfasst von Cristina Algieri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Dextromethorphan, Adenosine Triphosphate, Antitussive Agents, Mitochondrial Proton-Translocating ATPases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università di Bologna.
Abstract (Originalsprache)
Dextromethorphan (DXM), a widely used antitussive agent, was investigated for its effects on mitochondrial F 1 F O ‐ATPase activity and oxidative phosphorylation. Our results demonstrate that DXM inhibited F 1 F O ‐ATPase independently of the thiol redox state. Mutual exclusion analysis highlighted an overlapping binding site between DXM and dicyclohexylcarbodiimide (DCCD), indicating a shared or adjacent binding site in the membrane‐embedded F O domain of the enzyme. These findings suggested that DXM selectively targeted the proton translocation mechanism of F 1 F O ‐ATPase during the ATP hydrolysis and synthesis of ATP. Moreover, kinetic analysis confirmed a high affinity of DXM for the enzyme, with an inhibitory efficiency of 2.37 mM −1 ⸱s −1 . Importantly, DXM did not affect electron transport chain activity but impaired ATP synthesis, as evidenced by altered respiratory control ratios of oxidative phosphorylation. The data obtained offer new insights into its off‐target mitochondrial effects and potential implications for bioenergetic regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
- Department of Life Sciences, Health and Health Professions, Link University, Rome, Italy.
- IRCCS Neuromed, Pozzilli, Italy.
ORCID-Profile: Cristina Algieri, Fabiana Trombetti, Salvatore Nesci
Förderung
- Università di Bologna
Zitieren
APA
Algieri, C., Cugliari, A., Granata, S., Glogowski, P. A., Trombetti, F., Fabbri, M., Scainelli, L., & Nesci, S. (2026). Dextromethorphan Is a Novel Pharmacological Inhibitor of F 1 F O ‐ ATPase That Targets the Membrane‐Embedded Domain Impairing ATP Synthesis and Hydrolysis. BioFactors, 52(1). https://doi.org/10.1002/biof.70076
Vancouver
Algieri C, Cugliari A, Granata S, Glogowski PA, Trombetti F, Fabbri M, et al. Dextromethorphan Is a Novel Pharmacological Inhibitor of F 1 F O ‐ ATPase That Targets the Membrane‐Embedded Domain Impairing ATP Synthesis and Hydrolysis. BioFactors. 2026;52(1). doi:10.1002/biof.70076
BibTeX
@article{Algieri2026,
author = {Algieri, Cristina and Cugliari, Antonia and Granata, Silvia and Glogowski, Patrycja Anna and Trombetti, Fabiana and Fabbri, Micaela and Scainelli, Lucia and Nesci, Salvatore},
title = {Dextromethorphan Is a Novel Pharmacological Inhibitor of F 1 F O ‐ ATPase That Targets the Membrane‐Embedded Domain Impairing ATP Synthesis and Hydrolysis},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {1},
doi = {10.1002/biof.70076}
}
EUVIMED